Meeting
2024 ASCO Genitourinary Cancers Symposium
Prostate extracellular vesicles and prediction of clinically significant prostate cancer: A prospective single-institution pilot study.
Authors
Cameron J Britton
Mayo Clinic Rochester, Rochester, MN
Cameron J Britton , Jack R. Andrews , Ali Arafa , Yohan J Kim , Laureano J Rangel , Phillip J. Schulte , Vidhu B. Joshi , Mohamed E. Ahmed , R. Jeffrey Karnes , Fabrice Lucien
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Poster Session A: Prostate Cancer
Track
Prostate Cancer - Advanced,Prostate Cancer - Localized
Sub Track
Translational Research, Tumor Biology, Biomarkers, and Pathology
Citation
J Clin Oncol 42, 2024 (suppl 4; abstr 337)
DOI
10.1200/JCO.2024.42.4_suppl.337
Abstract #
337
Poster Bd #
P6
Abstract Disclosures
Similar Posters
Poster
2024 ASCO Genitourinary Cancers Symposium
Exploring the utility of prostate-derived extracellular vesicles as a urine biomarker for clinically significant prostate cancer.
First Author: Ekamjit Singh Deol
Poster
2019 Genitourinary Cancers Symposium
The predictive value of DRE in the modern era of prostate cancer diagnostics.
First Author: Joel Marcus Andersson
Poster
2018 Genitourinary Cancers Symposium
Serum neuroendocrine (NE) markers and clinical characteristics of treatment-emergent small cell neuroendocrine prostate cancer (t-SCNC) in men with metastatic castration resistant prostate cancer (mCRPC): Data from the West Coast Prostate Cancer Dream Team.
First Author: Rahul Raj Aggarwal
Poster
2018 Genitourinary Cancers Symposium
Are all biopsies created equal? comparison of extended sextant prostate biopsies performed with and without MRI-TRUS fusion biopsy system.
First Author: Graham R. Hale